Biofilms were assumed to be disorganized — bacteria embedded in a slimy matrix, stuck together but not arranged with any particular logic. The matrix was considered a shelter. The cells inside it were considered residents, not components of a structure.
Dietrich's group at Columbia found otherwise. In Pseudomonas aeruginosa biofilms, cells are packed lengthwise and oriented perpendicularly to the growth substrate. Clonal populations form visible striations running through the biofilm's depth. This is not random adhesion. It is architecture.
The arrangement creates metabolic zones. Cells at different depths within the biofilm are in different metabolic states — not because of genetic differences (they are clonal) but because of their physical position. The architecture determines which cells have access to nutrients and oxygen from the surface and which are starved in the interior. Peak metabolic activity shifts location depending on the biofilm's structure.
When the researchers disrupted the arrangement using mutant strains with disordered cell packing, the metabolic zoning changed. The mutant biofilms responded differently to both nutrients and antibiotics — specific subzones became more sensitive. The organization itself was providing antibiotic tolerance. Order, not chemistry, was the defense.
The through-claim: architecture is regulation. Identical cells in different positions behave differently because position determines access, and access determines metabolic state. The biofilm doesn't need signaling pathways to create metabolic diversity within a clonal population. It needs geometry. The physical arrangement of genetically identical cells produces functional heterogeneity — and that heterogeneity is what makes the biofilm resistant to treatment. Disrupting the building disrupts the function.